The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function
Open accessAbstract
The ARF tumor suppressor is a nucleolar protein that activates p53-dependent checkpoints by binding Mdm2, a p53 antagonist. Despite persuasive evidence that ARF can bind and inactivate Mdm2 in the nucleoplasm, the prevailing view is that ARF exerts its growth-inhibitory activities from within the nucleolus. We suggest ARF primarily functions outside the nucleolus and provide evidence that it is sequestered and held inactive in that compartment by a nucleolar phosphoprotein, nucleophosmin (NPM). Most cellular ARF is bound to NPM regardless of whether cells are proliferating or growth arrested, indicating that ARF-NPM association does not correlate with growth suppression. Notably, ARF binds NPM through the same domains that mediate nucleolar localization and Mdm2 binding, suggesting that NPM could control ARF localization and compete with Mdm2 for ARF association. Indeed, NPM knockdown markedly enhanced ARF-Mdm2 association and diminished ARF nucleolar localization. Those events correlated with greater ARF-mediated growth suppression and p53 activation. Conversely, NPM overexpression antagonized ARF function while increasing its nucleolar localization. These data suggest that NPM inhibits ARF's p53-dependent activity by targeting it to nucleoli and impairing ARF-Mdm2 association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Self-citationPomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“p53 is a transcription factor that activates numerous growth suppressive genes in response to cellular stresses (34), whereas Mdm2 is a p53-responsive gene that encodes an E3 ubiquitin ligase that plays a critical role in restricting p53 activity (50, 51).”
BackgroundThe complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
Major nucleolar proteins shuttle between nucleus and cytoplasm
Borer, R. A., Lehner, C. F., Eppenberger, H. M., & Nigg, E. A. (1989) · Cell · doi:10.1016/0092-8674(89)90241-9 · Cited by 1,114
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 996
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
Rubbi, C. P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg579 · Cited by 811
Structure and functions of nucleolin
Ginisty, H., Sicard, H., Roger, B., & Bouvet, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.6.761 · Cited by 774
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 3×
“Rather, most of the evidence suggests that ARF specifically counters the development of oncogenically transformed cancer cells (43, 86).”
BackgroundNucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication
Okuda, M., Horn, H. F., Tarapore, P., Tokuyama, Y., Smulian, A. G., Chan, P.-K., Knudsen, E. S., Hofmann, I. A., Snyder, J. D., Bove, K. E., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00093-3 · Cited by 685
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · cited 2×
“In the ARF-Mdm2-p53 pathway, phosphorylation plays an important role in regulating the functions of Mdm2 and p53 (18, 50).”
BackgroundE1A signaling to p53 involves the p19ARFtumor suppressor
de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 609
Zindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574
Self-citationP19 ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6937 · Cited by 540
Nucleophosmin regulates the stability and transcriptional activity of p53
Colombo, E., Marine, J.-C., Danovi, D., Falini, B., & Pelicci, P. G. (2002) · Nature Cell Biology · doi:10.1038/ncb814 · Cited by 528
Itahana, K., Bhat, K. P., Jin, A., Itahana, Y., Hawke, D., Kobayashi, R., & Zhang, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00431-3 · Cited by 432
Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D., & Laiho, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00110-2 · Cited by 416
Complex structure and regulation of the P16 (MTS1) locus.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383
Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23
Bertwistle, D., Sugimoto, M., & Sherr, C. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.985-996.2004 · Cited by 380
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
Raveh, T., Droguett, G., Horwitz, M. S., DePinho, R. A., & Kimchi, A. (2001) · Nature Cell Biology · doi:10.1038/35050500 · Cited by 361
Kalinichenko, V. V., Major, M. L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H. M., Dennewitz, M. B., Shin, B., Datta, A., Raychaudhuri, P., et al. (2004) · Genes & Development · doi:10.1101/gad.1200704 · Cited by 356
p53-independent functions of the p19ARF tumor suppressor
Weber, J. D., Jeffers, J. R., Rehg, J. E., Randle, D. H., Lozano, G., Roussel, M. F., Sherr, C. J., & Zambetti, G. P. (2000) · Genes & Development · doi:10.1101/gad.827300 · Cited by 354
Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329
Identification of c-myc responsive genes using rat cDNA microarray.
Guo, Q., Malek, R. L., Kim, H., Chiao, C., He, M., Ruffy, M., Sanka, K., Lee, N. H., Dang, C. V., & Liu, E. T. (2000) · PubMed · Cited by 310
p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
Carnero, A., Hudson, J. D., Price, C. M., & Beach, D. H. (2000) · Nature Cell Biology · doi:10.1038/35004020 · Cited by 279
Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex
Weber, J. D., Kuo, M.-L., Bothner, B., DiGiammarino, E. L., Kriwacki, R. W., Roussel, M. F., & Sherr, C. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2517-2528.2000 · Cited by 275
Yoneda‐Kato, N., Look, A. T., Kirstein, M. N., Valentine, M. B., Sc, R., Cohen, K. J., Carroll, A. J., & Morris, S. W. (1996) · PubMed · Cited by 274
Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing
Sugimoto, M., Kuo, M.-L., Roussel, M. F., & Sherr, C. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00057-1 · Cited by 273
Nucleolar protein B23 has molecular chaperone activities
Szebeni, A., & Olson, M. O. J. (1999) · Protein Science · doi:10.1110/ps.8.4.905 · Cited by 253
Mapping the Functional Domains of Nucleolar Protein B23
Hingorani, K., Szebeni, A., & Olson, M. O. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003278200 · Cited by 253
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
Llanos, S., Clark, P. A., Rowe, J., & Peters, G. (2001) · Nature Cell Biology · doi:10.1038/35074506 · Cited by 252
Midgley, C. A., Desterro, J. M., Saville, M. K., Howard, S., Sparks, A., Hay, R. T., & Lane, D. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203593 · Cited by 252
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
Chiarle, R., Gong, J. Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W. J., Dhall, G., Howes, J., Piva, R., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1343 · Cited by 252
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation
Lin, A. W., & Lowe, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091100298 · Cited by 215
Sensing Cellular Stress: Another New Function for the Nucleolus?
Olson, M. O. J. (2004) · Science's STKE · doi:10.1126/stke.2242004pe10 · Cited by 212
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
Kuo, M.-L., den Besten, W., Bertwistle, D., Roussel, M. F., & Sherr, C. J. (2004) · Genes & Development · doi:10.1101/gad.1213904 · Cited by 208
Derenzini, M. (2000) · Micron · doi:10.1016/s0968-4328(99)00067-0 · Cited by 197
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
Ries, S. J., Brandts, C. H., Chung, A. S., Biederer, C. H., Hann, B. C., Lipner, E. M., McCormick, F., & Michael Korn, W. (2000) · Nature Medicine · doi:10.1038/80466 · Cited by 189
Identification of a cryptic nucleolar-localization signal in MDM2
Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G., & Vousden, K. H. (2000) · Nature Cell Biology · doi:10.1038/35004057 · Cited by 189
Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson, D. C., Maréchal, V., Momand, J. A., Chen, J., Romocki, C., & Levine, A. J. (1993) · PubMed · Cited by 188
Arf tumor suppressor promoter monitors latent oncogenic signals in vivo
Zindy, F., Williams, R. T., Baudino, T. A., Rehg, J. E., Skapek, S. X., Cleveland, J. L., Roussel, M. F., & Sherr, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536808100 · Cited by 176
Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation
Daniely, Y., Dimitrova, D. D., & Borowiec, J. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.6014-6022.2002 · Cited by 171
Hypoxia-induced Nucleophosmin Protects Cell Death through Inhibition of p53
Li, J., Zhang, X., Sejas, D. P., Bagby, G. C., & Pang, Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400297200 · Cited by 171
p19ARF targets certain E2F species for degradation
Martelli, F., Hamilton, T., Silver, D. P., Sharpless, N. E., Bardeesy, N., Rokas, M., DePinho, R. A., Livingston, D. M., & Grossman, S. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081061398 · Cited by 166
Human ARF binds E2F1 and inhibits its transcriptional activity
Eymin, B., Karayan, L., Séité, P., Brambilla, C., Brambilla, E., Larsen, C.-J., & Gazzéri, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204220 · Cited by 160
EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA
Nozawa, Y., van Belzen, N., MADE, A. C. J. V. D., Dinjens, W. N. M., & Bosman, F. T. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199601)178:1<48::aid-path432>3.0.co;2-y · Cited by 154
C23 Interacts with B23, A Putative Nucleolar‐Localization‐Signal‐Binding Protein
Li, Y., Busch, R. K., Valdez, B. C., & Busch, H. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0153n.x · Cited by 154
Zhao, L., Samuels, T. L., Winckler, S., Korgaonkar, C. K., Tompkins, V. S., Horne, M. C., & Quelle, D. E. (2003) · PubMed · Cited by 149
Self-citationCharacterization of Nucleophosmin (B23) as a Myc Target by Scanning Chromatin Immunoprecipitation
Zeller, K. I., Haggerty, T. J., Barrett, J. F., Guo, Q. M., Wonsey, D. R., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108506200 · Cited by 148
Variations on a theme: the alternate translocations in APL
Redner, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402720 · Cited by 142
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development
McKeller, R. N., Fowler, J. L., Cunningham, J. J., Warner, N., Smeyne, R. J., Zindy, F., & Skapek, S. X. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052484199 · Cited by 132
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 131
Self-citationA new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.
Duro, D., Bernard, O., Della-Valle, V., Berger, R., & Larsen, C. (1995) · PubMed · Cited by 130
Fátyol, K., & Szalay, A. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102847200 · Cited by 125
Biggiogera, M., Bürki, K., Kaufmann, S. H., Shaper, J. H., Gas, N., Amalric, F., & Fakan, S. (1990) · Development · doi:10.1242/dev.110.4.1263 · Cited by 111
Wu, M. H., Chang, J. H., & Yung, B. Y. M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.93 · Cited by 110
Li, Y. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.4098-4102.1997 · Cited by 93
Contribution of two independent MDM2-binding domains in p14ARF to p53 stabilization
Lohrum, M. A. E., Ashcroft, M. A., Kubbutat, M. H. G., & Vousden, K. H. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00472-3 · Cited by 91
Immunolocalization of Human p14ARF to the Granular Component of the Interphase Nucleolus
Lindström, M. S., Klangby, U., Inoue, R., Pisa, P., Wiman, K. G., & Asker, C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4854 · Cited by 83
Henry, M. K., Lynch, J. T., Eapen, A. K., & Quelle, F. W. (2001) · Blood · doi:10.1182/blood.v98.3.834 · Cited by 80
Self-citationAssociation of p14ARF with the p120E4FTranscriptional Repressor Enhances Cell Cycle Inhibition
Rizos, H., Diefenbach, E., Badhwar, P., Woodruff, S., Becker, T. M., Rooney, R. J., & Kefford, R. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210978200 · Cited by 77
CARF Is a Novel Protein That Cooperates with Mouse p19 (Human p14 ) in Activating p53
Hasan, M. K., Yaguchi, T., Sugihara, T., Kumar, P. K. R., Taira, K., Reddel, R. R., Kaul, S. C., & Wadhwa, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204177200 · Cited by 77
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
Jackson, M. W., Lindström, M. S., & Berberich, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010685200 · Cited by 74
Differential Regulation of E2F1, DP1, and the E2F1/DP1 Complex by ARF
Datta, A., Nag, A., & Raychaudhuri, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8398-8408.2002 · Cited by 72
Net Results of Nucleolar Dynamics
Garcia, S. N., & Pillus, L. (1999) · Cell · doi:10.1016/s0092-8674(00)80794-1 · Cited by 66
Stability of nucleolar versus non-nucleolar forms of human p14ARF
RODWAY, H. A., Llanos, S., Rowe, J., & Peters, G. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207854 · Cited by 63
Modestou, M., Puig-Antich, V., Korgaonkar, C. K., Eapen, A. K., & Quelle, D. E. (2001) · PubMed · Cited by 48
Self-citationPex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway*
Sugihara, T., Kaul, S. C., Kato, J., Reddel, R. R., Nomura, H., & Wadhwa, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100011200 · Cited by 47
Oligomerization of the Human ARF Tumor Suppressor and Its Response to Oxidative Stress
Ménendez, S., Khan, Z., Coomber, D., Lane, D. P., Higgins, M., Koufali, M. M., & Laín, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211007200 · Cited by 41
David-Pfeuty, T., & Nouvian-Dooghe, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205871 · Cited by 32
Monoclonal Antibodies to the Mouse p19 Arf Tumor Suppressor Protein
Bertwistle, D., Zindy, F., Sherr, C. J., & Roussel, M. F. (2004) · Hybridoma and Hybridomics · doi:10.1089/hyb.2004.23.293 · Cited by 30
Mdm2 Regulates p53 Independently of p19ARF in Homeostatic Tissues
O’Leary, K. A., Mendrysa, S. M., Vaccaro, A. M., & Perry, M. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.186-191.2004 · Cited by 25
P19ARF inhibits the functions of the HPV16 E7 oncoprotein
Pan, W., Datta, A., Adami, G. R., Raychaudhuri, P., & Bagchi, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206857 · Cited by 18
Cited by
Grisendi, S., Mecucci, C., Falini, B., & Pandolfi, P. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1885 · Cited by 850
Divorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
Falini, B., Nicoletti, I., Martelli, M. F., & Mecucci, C. (2007) · Blood · doi:10.1182/blood-2006-07-012252 · Cited by 565
Role of nucleophosmin in embryonic development and tumorigenesis
Grisendi, S., Bernardi, R., Rossi, M., Cheng, K., Khandker, L., Manova, K., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03915 · Cited by 561
ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor
Chen, D., Kon, N., Li, M., Zhang, W., Qin, J., & Gu, W. (2005) · Cell · doi:10.1016/j.cell.2005.03.037 · Cited by 544
Metadata
- Authors
- Korgaonkar, C., Hagen, J., Tompkins, V., Frazier, A. A., Allamargot, C., Quelle, F. W., & Quelle, D. E.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2005-02-01
- Volume
- 25
- Issue
- 4
- Pages
- 1258-1271
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2155781667
- Cited by
- 292
- References
- 83
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.